Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
Progress in the treatment of glioblastoma multiforme (GBM) over the last few decades has remained marginal and GBM is still universally fatal with short survival times after initial diagnosis. Much research is focused on finding new therapeutics for GBM and immune based approaches have shown great p...
Main Authors: | Andrea eSchuessler, David eWalker, Rajiv eKhanna |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00275/full |
Similar Items
-
Impact of pre‐therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV‐specific T‐cell therapy
by: David G Walker, et al.
Published: (2019-01-01) -
Current Immunotherapies for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2021-03-01) -
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
by: Joshua R. D. Pearson, et al.
Published: (2020-10-01) -
Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme
by: Jilesen, Zachary Keavin
Published: (2019) -
Salvage fractionated Stereotactic Radiotherapy (fSRT) with or without chemotherapy and immunotherapy for recurrent Glioblastoma Multiforme: A single institution experience
by: Shaakir eHasan, et al.
Published: (2015-05-01)